Jiangsu Jibeier Pharmaceutical Co Ltd (688566.SS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE100004041
Jiangsu Jibeier Pharmaceutical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 896.53 m CNY | 964.93 m CNY |
| Gross profit | 801.28 m CNY | 964.93 m CNY |
| Operating income | 254.66 m CNY | 252.76 m CNY |
| EBIT | 253.60 m CNY | 298.21 m CNY |
| Net income | 219.33 m CNY | 258.67 m CNY |
| Diluted EPS – continuing operations | 1.13 CNY | 1.30 CNY |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Jiangsu Jibeier Pharmaceutical Co Ltd
Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the drug research and development and production in China. The company's products cover multiple therapeutic areas such as increasing white blood cells, fighting hypertension, enhancing immunity, treating joint diseases, fighting eye infections, treating bronchitis, protecting liver function, etc. It is also developing drugs for the treatment of depression, tumors, stomach and gastric diseases, and other diseases. In addition, the company offers its products in tablets, capsules, and eye drops forms. Jiangsu Jibeier Pharmaceutical Co., Ltd. was founded in 2001 and is based in Zhenjiang, China.
More stocks
- Clevo Co (2362.TW)
- Synergie SE (SDG.PA)
- Hexatronic Group AB (HTRO.ST)
- Jiangsu Jiangnan Water Co Ltd (601199.SS)
- Poly Plastic Masterbatch Suzhou Co (300905.SZ)
- Wuxi Jinyang New Materials Co. Ltd. A (301210.SZ)
- Viridien SA (VIRI.PA)
- K2A Knaust & Andersson Fastigheter AB (publ) (K2A PREF.ST)
- Shenzhen LeoKing Environmental Group Co. Ltd. A (301305.SZ)
- FastPartner AB (FPAR A.ST)
- Criteo S.A. (CRTO)
- WAM Capital Ltd (WAM.AX)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.